Pfizer, BioNTech to Supply Japan With 120 Million Doses of COVID-19 Vaccine

Pfizer and BioNTech have signed an agreement with Japan’s Ministry of Health to supply the country with 120 million doses of their COVID-19 vaccine.

The companies did not disclose the financial terms of the agreement but said they are based on the timing of delivery and the volume of doses. Deliveries are planned to begin in the first half of 2021.

Pfizer and BioNTech began a phase 2/3 trial of their lead COVID-19 vaccine candidate BNT162b2 on July 27.